Diabetes & Polygraph Testing: Blood Sugar Effects on Results

What Is Diabetes and Why Does It Matter for Polygraph Testing?

Diabetes mellitus is a chronic metabolic disorder characterized by the body's inability to properly regulate blood glucose levels. According to the IDF Diabetes Atlas 11th edition (2025), over 500 million adults worldwide are living with diabetes, and that number is projected to rise to close to 900 million by 2050 [1]Verified IDF Diabetes Atlas 11th Edition — Global Prevalence Estimates for 2024 and Projections for 2050
Confirms over 500 million adults living with diabetes worldwide in 2024, projected to rise to 900 million by 2050. In the United States, approximately 40.1 million people — roughly 12% of the population — have diabetes according to the CDC's National Diabetes Statistics Report (2023 data), with an estimated 11 million of those cases remaining undiagnosed [2]Verified National Diabetes Statistics Report
Confirms 40.1 million Americans with diabetes (12% of population), including 11 million undiagnosed. This makes diabetes one of the most common medical conditions a polygraph examiner will encounter.

The relevance of diabetes to polygraph testing is profound and direct. Polygraph instruments measure physiological responses controlled by the autonomic nervous system (ANS) — the same system that diabetes progressively damages [3]Verified Beyond the Polygraph: Deception Detection and the Autonomic Nervous System
Confirms diabetes mellitus is listed as a condition affecting polygraph blood pressure, heart rate, and perspiration channels. A peer-reviewed article published in Federal Practitioner specifically identified diabetes mellitus as a condition that can affect polygraph blood pressure, heart rate, and perspiration measurements [4]Verified Beyond the Polygraph: Deception Detection and the Autonomic Nervous System (Medication Effects)
Confirms diabetes patients have elevated resting heart rate and low HRV due to dysregulated beta-adrenergic activity; documents medication effects on ANS. The ANS consists of two branches: the sympathetic nervous system (responsible for "fight or flight" responses) and the parasympathetic nervous system (responsible for "rest and digest" functions). A polygraph works by detecting changes in the balance between these two branches when a person responds to questions.

In a healthy individual, relevant questions that produce psychological stress trigger a measurable sympathetic response — increased heart rate, elevated blood pressure, changes in breathing patterns, and increased sweat gland activity. When diabetes disrupts the ANS, the reliability of these measurements can be significantly compromised. Research on individual traits and polygraph outcomes confirms that examinees' physiological characteristics influence test results [5]Verified Effects of Individual Traits on Polygraph Test Results
Confirms examinees' demographic and physiological traits influence polygraph outcomes. Understanding medical suitability is a core competency for professional examiners — for a broader overview of conditions that may affect testing, see our guide on thyroid disorders and polygraph accuracy.

Type 1 vs. Type 2: Key Differences Relevant to Polygraph

Type 1 diabetes is an autoimmune condition where the body's immune system destroys the insulin-producing beta cells in the pancreas. People with Type 1 diabetes produce little or no insulin and must rely on external insulin administration to survive. According to the CDC, in the United States about 2.1 million people have diagnosed type 1 diabetes, including approximately 314,000 children and adolescents [2]Verified National Diabetes Statistics Report
Confirms 40.1 million Americans with diabetes (12% of population), including 11 million undiagnosed. This form accounts for approximately 5-10% of all diabetes cases [2]Verified National Diabetes Statistics Report
Confirms 40.1 million Americans with diabetes (12% of population), including 11 million undiagnosed.

Type 2 diabetes is a metabolic condition characterized by insulin resistance — the body produces insulin but cannot use it effectively. Over time, the pancreas may also produce less insulin. Over 90% of people with diabetes have type 2, which is driven by socio-economic, demographic, environmental, and genetic factors [1]Verified IDF Diabetes Atlas 11th Edition — Global Prevalence Estimates for 2024 and Projections for 2050
Confirms over 500 million adults living with diabetes worldwide in 2024, projected to rise to 900 million by 2050. It typically develops in adulthood, though increasing rates of childhood obesity have led to more pediatric Type 2 diagnoses.

For polygraph purposes, the type of diabetes matters because it affects the stability and predictability of blood glucose levels. Type 1 diabetics are generally more prone to rapid glucose swings (both high and low), while Type 2 diabetics tend to have more sustained hyperglycemia. Both conditions can cause autonomic neuropathy over time, but the progression and severity patterns differ. In particular, patients with Type 2 diabetes may present with neuropathy at diagnosis or even during the prediabetic stage [6]Verified Cardiac Autonomic Neuropathy in Diabetes Mellitus: Pathogenesis, Epidemiology, Diagnosis and Clinical Implications
Confirms diabetic neuropathy develops in at least 50% of people with diabetes; CAN prevalence increases with duration.

The Autonomic Nervous System Connection

The autonomic nervous system is the bridge between diabetes and polygraph validity. Over time, chronic hyperglycemia damages small blood vessels and nerves throughout the body, a process known as diabetic neuropathy. When this damage affects the autonomic nerves — a condition called diabetic autonomic neuropathy (DAN) — it can impair the body's ability to regulate heart rate, blood pressure, sweating, and other involuntary functions.

Multiple peer-reviewed studies confirm that diabetic peripheral neuropathy affects approximately 50% of adults with diabetes during their lifetime [7]Verified Epidemiology of Peripheral Neuropathy and Lower Extremity Disease in Diabetes
Confirms diabetic peripheral neuropathy affects approximately 50% of adults with diabetes during their lifetime. Cardiovascular autonomic neuropathy (CAN), which is the form most directly relevant to polygraph testing, affects approximately 20% of people with diabetes according to a 2024 review published in Diabetologia [8]Verified Cardiovascular Autonomic Neuropathy in Diabetes: An Update with a Focus on Management
Confirms CAN affects approximately 20% of people with diabetes; highlights CAN presence in prediabetes. The Consensus Panel on Diabetic Neuropathy estimated CAN prevalence to be 20%-65% in an unselected population of type 1 or type 2 diabetic patients, with variability depending on clinical and demographic factors [9]Verified A Review on Autonomic Functional Assessment in Diabetic Patients
Confirms Consensus Panel estimated CAN prevalence of 20-65% in unselected diabetic populations. The CAN Subcommittee of the Toronto Consensus Panel defines CAN as an "impairment of cardiovascular autonomic control in patients with established diabetes" [10]Verified Cardiac Autonomic Neuropathy in Diabetes Mellitus
Confirms CAN prevalence ranges from 2.5% to 90% depending on population; describes resting tachycardia and vagal damage mechanisms.

The implications for polygraph testing are significant:

Cardiovascular autonomic neuropathy reduces heart rate variability, impairs blood pressure regulation, and can cause orthostatic hypotension (sudden blood pressure drops when sitting or standing) [10]Verified Cardiac Autonomic Neuropathy in Diabetes Mellitus
Confirms CAN prevalence ranges from 2.5% to 90% depending on population; describes resting tachycardia and vagal damage mechanisms. CAN often first manifests as damage to the vagus nerve, which is responsible for roughly three-quarters of parasympathetic activity [10]Verified Cardiac Autonomic Neuropathy in Diabetes Mellitus
Confirms CAN prevalence ranges from 2.5% to 90% depending on population; describes resting tachycardia and vagal damage mechanisms.

Sudomotor neuropathy (damage to sweat gland nerves) directly affects electrodermal activity — the polygraph channel that measures galvanic skin response through perspiration changes. Research has established that the electrodermal channel provides the most diagnostic information of all polygraph channels [11]Verified Relative Accuracy of Polygraph Examiner Diagnosis of Respiration, Blood Pressure, and GSR Recordings
Confirms electrodermal (GSR) measures provide the most diagnostic information of all polygraph channels, making sudomotor impairment especially concerning.

Gastroparesis (delayed stomach emptying) can cause discomfort and distraction during testing, introducing movement artifacts into chart data.

The interaction between diabetes and the autonomic nervous system is what makes this condition uniquely challenging for polygraph testing — it doesn't just introduce noise into one channel; it can systematically affect all channels the instrument measures.

The Three Primary Polygraph Channels

To understand how diabetes affects polygraph accuracy, it's essential to understand what a polygraph actually measures. Modern polygraph instruments simultaneously record data from three primary physiological channels. Each channel captures different autonomic nervous system activity, and together they provide the data examiners use to make determinations about truthfulness.

1. Pneumograph (Respiratory Activity): Two pneumograph components — thoracic (chest) and abdominal — are placed around the examinee's torso using expandable rubber tubes or electronic sensors. These measure the rate, depth, and pattern of breathing. During deception, individuals may exhibit changes such as shallower breathing, suppressed respiration, or irregular breathing patterns. Diabetes can affect respiratory patterns through metabolic acidosis during severe hyperglycemia (Kussmaul breathing) and through anxiety-related hyperventilation during hypoglycemia.

2. Electrodermal Activity (EDA/Galvanic Skin Response): Finger plates or electrodes placed on the fingertips measure changes in electrical conductivity of the skin caused by sweat gland activity. The eccrine sweat glands on the palms and fingers are innervated by the sympathetic nervous system, making EDA one of the most sensitive indicators of autonomic arousal. Field research has demonstrated that electrodermal (GSR) measures provide the most diagnostic information of all polygraph channels, followed by cardiovascular and respiratory channels [11]Verified Relative Accuracy of Polygraph Examiner Diagnosis of Respiration, Blood Pressure, and GSR Recordings
Confirms electrodermal (GSR) measures provide the most diagnostic information of all polygraph channels. Diabetes can significantly impair EDA responses through sudomotor neuropathy and dehydration. The spontaneous fluctuation rate of skin conductance is a key marker that examiners use to assess electrodermal responsiveness, and this rate can be profoundly affected by diabetic nerve damage.

3. Cardiovascular Activity: A standard blood pressure cuff (typically inflated to approximately 60 mmHg — below diastolic pressure) is placed on the upper arm to record relative changes in blood pressure, heart rate, and pulse amplitude. Some modern instruments also use finger plethysmographs for additional cardiovascular data. Diabetes directly affects cardiovascular parameters through autonomic neuropathy, vascular stiffness, and fluctuating blood glucose levels.

How These Channels Create a Polygraph Determination

During a properly conducted polygraph examination, the examiner presents a series of questions while the instrument continuously records data from all channels. The examiner then compares physiological responses to relevant questions (about the issue under investigation) against responses to comparison questions (designed to produce a known stress response in truthful individuals). This comparison process is the foundation of modern polygraph technique formats. A meta-analysis of the comparison question polygraph test found overall accuracy estimates above 85% across studies, identifying important moderator variables including examiner training, question format, and testing protocols [12]Verified A Meta-Analysis of the Comparison Question Polygraph Test: Moderator Effects
Confirms overall CQT accuracy estimates above 85% across studies; identifies key moderator variables.

The underlying assumption is that a deceptive person will show greater physiological reactivity to relevant questions, while a truthful person will show greater reactivity to comparison questions. Early psychophysiological research evaluated whether polygraph responses represent specific deception-related effects or general arousal, contributing to the theoretical understanding of what polygraphs actually measure [13]Verified Evaluating Polygraphy from a Psychophysiological Perspective: A Specific-Effects Analysis
Foundational research on whether polygraph responses represent specific deception-related effects or general arousal. When diabetes distorts the baseline physiological state or impairs the body's ability to produce differential responses, the entire comparison framework is compromised. This is why diabetes is not merely a comfort concern — it is a scientific validity concern that can directly affect the accuracy of test outcomes.

Examiners using formats such as the Directed Lie Screening Test (DLST) or Directed Lie Comparison Questions should be especially attentive to how diabetes may affect baseline reactivity, as these formats depend on the examinee's ability to produce measurable physiological responses to known-lie comparison questions. Different numerical chart evaluation systems can produce varying outcomes [14]Verified Effects of differing numerical chart evaluation systems on polygraph examination results
Confirms different numerical scoring systems produce varying outcomes, relevant to chart evaluation of diabetic examinees, making it all the more important that charts from diabetic examinees are evaluated with awareness of the underlying medical condition.

How Elevated Blood Glucose Distorts Polygraph Channels

Hyperglycemia — defined as blood glucose levels above 180 mg/dL (10.0 mmol/L) — triggers a cascade of physiological changes that directly interfere with polygraph measurements. When blood sugar is chronically or acutely elevated, the body experiences a state of metabolic stress that can mimic, mask, or amplify the physiological indicators a polygraph instrument is designed to detect.

Cardiovascular Effects of Hyperglycemia: Elevated blood glucose stimulates sympathetic nervous system activity, raising baseline heart rate and reducing the instrument's ability to detect small, question-specific heart rate changes associated with deception. Research confirms that hyperglycemia increases activity of the sympathetic nervous system while simultaneously downregulating parasympathetic activity by suppressing the vagus nerve [15]Verified Does Blood Sugar Affect Heart Rate? (Levels Health)
Confirms hyperglycemia increases sympathetic nervous system activity and simultaneously downregulates parasympathetic activity. In patients with diabetes mellitus, this often results in an elevated resting heart rate and low heart rate variability due to dysregulated beta-adrenergic activity [4]Verified Beyond the Polygraph: Deception Detection and the Autonomic Nervous System (Medication Effects)
Confirms diabetes patients have elevated resting heart rate and low HRV due to dysregulated beta-adrenergic activity; documents medication effects on ANS. Hyperglycemia also causes osmotic fluid shifts and vascular inflammation, raising blood pressure. An already-elevated blood pressure reading makes it harder to identify the relative blood pressure increases that occur in response to relevant questions. Chronic hyperglycemia damages vagal nerve function, reducing the natural beat-to-beat variation in heart rate — the very thing a polygraph needs to differentiate between question types [10]Verified Cardiac Autonomic Neuropathy in Diabetes Mellitus
Confirms CAN prevalence ranges from 2.5% to 90% depending on population; describes resting tachycardia and vagal damage mechanisms.

Electrodermal Effects of Hyperglycemia: Hyperglycemia causes osmotic diuresis (excess urination), leading to dehydration. Dehydrated skin has lower baseline conductance and may produce attenuated EDA responses, making it harder to score meaningful electrodermal reactions. Elevated blood glucose increases blood osmolarity, which can affect the concentration of electrolytes in sweat, changing the electrical properties of the skin surface.

Respiratory Effects of Hyperglycemia: In severe hyperglycemia approaching diabetic ketoacidosis (DKA), the body compensates for metabolic acidosis with deep, labored Kussmaul breathing. This distinctive respiratory pattern would completely overwhelm normal question-related breathing changes on the pneumograph. Even moderate hyperglycemia can increase baseline respiratory rate, introducing confounding variables into the respiratory channel.

The False Negative Risk: How Hyperglycemia Can Mask Deception

One of the most concerning effects of hyperglycemia during polygraph testing is the potential for false negative results — outcomes where a deceptive individual appears truthful. When the baseline physiological state is already elevated (high heart rate, high blood pressure, dampened EDA), there is less physiological "headroom" for stress-related responses to relevant questions. The signal-to-noise ratio decreases — the deception-related physiological changes are smaller relative to the already-noisy baseline.

Additionally, autonomic neuropathy associated with chronic hyperglycemia can blunt the sympathetic nervous system's ability to mount a response at all. If the nerves responsible for increasing heart rate, triggering perspiration, or constricting blood vessels are damaged, the body simply cannot produce the responses a polygraph instrument is designed to detect. Studies examining physiological responses under realistic stress conditions demonstrate that stress levels significantly influence detection accuracy [16]Verified Effects of Realistic Stress and the Role of 'Lying' in Psychophysiological Detection
Confirms realistic stress conditions influence detection accuracy differently than laboratory conditions, and the metabolic stress of hyperglycemia adds an uncontrolled variable.

This is why examiners must be aware of these dynamics and document them appropriately. Failing to account for hyperglycemia-related physiological distortion could lead to an inaccurate determination. Higher motivation in examinees typically produces larger physiological differences between truth and deception [17]Verified The Effects of Motivation on the Detection of Deception in CQT
Confirms higher motivation produces larger physiological differences between truth and deception, but even highly motivated diabetic examinees may produce dampened responses if their blood glucose is poorly controlled.

The Sympathetic Surge: How Low Blood Sugar Mimics Deception

Hypoglycemia — blood glucose levels below 70 mg/dL (3.9 mmol/L) — represents arguably the more dangerous scenario for polygraph accuracy. When blood sugar drops below the normal threshold, the body activates its counterregulatory response, which is essentially a sympathetic nervous system emergency alarm. Research published in Endocrinology confirms that hypoglycemia activates the autonomic nervous system, mediating a cascade of counterregulatory responses [18]Verified Minireview: The Role of the Autonomic Nervous System in Mediating the Glucagon Response to Hypoglycemia
Confirms hypoglycemia activates the autonomic nervous system including sympathetic nerves and adrenal medullary epinephrine. This response produces physiological symptoms that are virtually indistinguishable from the stress responses associated with deception.

The counterregulatory response to hypoglycemia includes: epinephrine (adrenaline) release from the adrenal glands, causing rapid heartbeat, increased blood pressure, sweating, trembling, and heightened anxiety — all symptoms that would register as significant responses on every polygraph channel [19]Verified Stress, Hypoglycemia, and the Autonomic Nervous System
Confirms hypoglycemia evokes autonomic, neuroendocrine, and immune responses including increased sympathetic activation. Profuse sweating (diaphoresis) is one of the earliest and most pronounced symptoms of hypoglycemia, which on the electrodermal channel would produce dramatic spikes in skin conductance that could easily be interpreted as deception-related responses. The cardiovascular response to hypoglycemia produces rapid, forceful heartbeats and elevated blood pressure — the same patterns examiners look for as indicators of deception.

Hypoglycemia also produces intense anxiety, irritability, and difficulty concentrating [19]Verified Stress, Hypoglycemia, and the Autonomic Nervous System
Confirms hypoglycemia evokes autonomic, neuroendocrine, and immune responses including increased sympathetic activation. These psychological states create generalized sympathetic arousal that elevates all physiological channels, making it nearly impossible to isolate question-specific responses. Physical trembling and involuntary movements introduce motion artifacts into all channels, further contaminating the data.

Why Hypoglycemia Creates False Positive Results

The physiological profile of hypoglycemia creates a near-perfect scenario for false positive results — outcomes where a truthful individual appears deceptive. During a standard comparison question format examination, the examiner expects to see larger responses to comparison questions in truthful subjects and larger responses to relevant questions in deceptive subjects. However, when hypoglycemia triggers a generalized sympathetic activation, the examinee produces elevated responses across all question types — but particularly during relevant questions.

This occurs because relevant questions naturally carry more psychological weight for the examinee. When the baseline nervous system is already in a heightened state from hypoglycemia, the additive effect of even mild psychological stress from relevant questions can produce exaggerated responses that score in the deceptive range. Meanwhile, the comparison questions may not trigger proportionally larger responses because the hypoglycemia-induced arousal already dominates the physiological landscape.

The risk is especially acute with hypoglycemia unawareness — a condition common in long-standing Type 1 diabetics where the body stops producing warning symptoms when blood sugar drops. This is part of a phenomenon described in the medical literature as hypoglycemia-associated autonomic failure (HAAF), where antecedent hypoglycemia impairs hormonal and autonomic responses to subsequent hypoglycemia [20]Verified Cardiac Autonomic Neuropathy in Diabetes (Diabetes Care Position Statement)
Confirms hypoglycemia impairs hormonal and autonomic responses to subsequent hypoglycemia; describes HAAF. In these individuals, cognitive function deteriorates silently, potentially affecting their ability to understand questions, process information, and form accurate memories during the pre-test interview. This can compromise the entire examination without any obvious external signs.

For examiners, it is critical to understand that failed polygraph results may influence confession behavior [21]Verified Effects of Failed Polygraph Results on True and False Confessions
Foundational research on how failed polygraph outcomes affect confession behavior, relevant to false positive risks in diabetic examinees. A false positive on a truthful diabetic examinee could have significant downstream consequences, making glucose verification before testing essential.

Types of Diabetic Neuropathy That Affect Polygraph Testing

Diabetic neuropathy is progressive nerve damage caused by prolonged exposure to high blood glucose levels. Peer-reviewed research confirms that approximately 50% of adults with diabetes are affected by peripheral neuropathy over their lifetime [7]Verified Epidemiology of Peripheral Neuropathy and Lower Extremity Disease in Diabetes
Confirms diabetic peripheral neuropathy affects approximately 50% of adults with diabetes during their lifetime, and it represents the most serious long-term concern for polygraph validity. Several distinct forms of neuropathy have direct implications for polygraph testing.

Cardiovascular Autonomic Neuropathy (CAN): CAN is damage to the autonomic nerves that control the heart and blood vessels. Published data from Diabetologia indicate that CAN affects approximately 20% of people with diabetes [8]Verified Cardiovascular Autonomic Neuropathy in Diabetes: An Update with a Focus on Management
Confirms CAN affects approximately 20% of people with diabetes; highlights CAN presence in prediabetes, though the prevalence can range from 2.5% in newly diagnosed patients to much higher rates in those with long-standing disease [10]Verified Cardiac Autonomic Neuropathy in Diabetes Mellitus
Confirms CAN prevalence ranges from 2.5% to 90% depending on population; describes resting tachycardia and vagal damage mechanisms. CAN manifests as resting tachycardia (a fixed, elevated heart rate often above 100 bpm that doesn't change normally in response to stimuli, dramatically reducing the cardiovascular channel's utility for scoring), exercise intolerance, and orthostatic hypotension with blood pressure drops of 20+ mmHg systolic when changing position [10]Verified Cardiac Autonomic Neuropathy in Diabetes Mellitus
Confirms CAN prevalence ranges from 2.5% to 90% depending on population; describes resting tachycardia and vagal damage mechanisms. CAN initially manifests as vagus nerve damage causing resting tachycardia and decreased parasympathetic tone, with sympathetic denervation occurring in later stages [10]Verified Cardiac Autonomic Neuropathy in Diabetes Mellitus
Confirms CAN prevalence ranges from 2.5% to 90% depending on population; describes resting tachycardia and vagal damage mechanisms.

Sudomotor Neuropathy: This form of neuropathy specifically damages the nerves that control sweat glands. Anhidrosis (inability to sweat) in severe cases can render the EDA channel essentially non-functional. Sweat gland dysfunction typically begins in the feet and hands — precisely where EDA electrodes are placed — making the fingers the most affected area for polygraph purposes.

Peripheral Neuropathy: While primarily affecting sensation in the extremities, peripheral neuropathy can indirectly affect polygraph testing through altered pain perception that changes responses to blood pressure cuff inflation, restless movements that introduce motion artifacts, and general discomfort that creates baseline elevation across all channels. Examiners should also be aware that conditions involving purposeful non-cooperation can be difficult to distinguish from genuine neuropathy-related signal attenuation.

When Neuropathy Makes Polygraph Testing Unsuitable

Not all diabetic neuropathy renders polygraph testing invalid. Mild to moderate neuropathy, when documented and accounted for, typically still allows for valid testing. However, certain indicators suggest that testing may produce unreliable results:

Severe CAN with resting tachycardia above 100 bpm and minimal heart rate variability is a strong contraindication. When the heart rate is essentially fixed, the cardiovascular channel cannot contribute meaningful data to the examination.

Documented anhidrosis or severe sudomotor dysfunction in the hands eliminates the electrodermal channel. Since research confirms that the electrodermal channel provides the most diagnostic information [11]Verified Relative Accuracy of Polygraph Examiner Diagnosis of Respiration, Blood Pressure, and GSR Recordings
Confirms electrodermal (GSR) measures provide the most diagnostic information of all polygraph channels, its loss significantly compromises examination validity.

Frequent hypoglycemic episodes, particularly with hypoglycemia unawareness, suggest that maintaining stable blood glucose during a 3-4 hour examination may not be feasible.

Examiners should discuss concerns openly, similar to the considerations involved with conditions like autism spectrum disorder or OCD, where the examiner must assess whether the individual can produce valid physiological responses. In some cases, it may be appropriate to consult with the examinee's endocrinologist before scheduling a test.

How Common Diabetes Drugs Affect Polygraph Physiology

Several categories of diabetes medications can independently affect polygraph-relevant physiology, and examiners must document all medications during the pre-test interview. A peer-reviewed review published in Federal Practitioner specifically noted that many commonly prescribed medications have effects on the autonomic nervous system that could affect polygraph exam results [4]Verified Beyond the Polygraph: Deception Detection and the Autonomic Nervous System (Medication Effects)
Confirms diabetes patients have elevated resting heart rate and low HRV due to dysregulated beta-adrenergic activity; documents medication effects on ANS.

Insulin (all types — rapid-acting, long-acting, mixed): The primary risk with insulin is iatrogenic hypoglycemia. If a patient has taken insulin but not eaten adequately, blood sugar may drop during the examination, producing the sympathetic activation patterns discussed above. Examiners should confirm the timing of the examinee's last insulin dose and meal.

Metformin (Glucophage): The most commonly prescribed diabetes medication. Metformin primarily works by reducing hepatic glucose production and improving insulin sensitivity. It carries a lower risk of hypoglycemia than insulin or sulfonylureas. Its most significant polygraph-relevant side effect is gastrointestinal distress, which can create discomfort and movement artifacts.

Sulfonylureas (glipizide, glyburide, glimepiride): These medications stimulate the pancreas to produce more insulin and carry a meaningful risk of hypoglycemia, particularly in older patients or when combined with other glucose-lowering agents.

Beta-blockers (often prescribed to diabetics for cardiovascular protection): These are especially important for polygraph purposes. Beta-blockers reduce heart rate, heart rate variability, cardiac contractility, and blood pressure — blunting the physiological stress response that polygraphs are designed to detect [4]Verified Beyond the Polygraph: Deception Detection and the Autonomic Nervous System (Medication Effects)
Confirms diabetes patients have elevated resting heart rate and low HRV due to dysregulated beta-adrenergic activity; documents medication effects on ANS. A patient taking beta-blockers will have dampened physiological responses across all cardiovascular parameters.

SGLT2 inhibitors (empagliflozin, dapagliflozin): These newer medications work by causing the kidneys to excrete excess glucose in urine. They increase urination and can cause dehydration — potentially reducing skin conductance and affecting the EDA channel.

The pre-test questionnaire should capture all medications, dosages, and timing of last doses. Examiners should record this information and note any expected physiological effects in their documentation.

Essential Pre-Test Glucose Verification

Before commencing any polygraph examination on a diabetic examinee, the examiner should verify that blood glucose is within a safe and physiologically stable range of 70-180 mg/dL. This range aligns with the American Diabetes Association's recommended target range and minimizes the risk of glucose-related physiological distortion.

Examinees should be asked to check their blood glucose using their own glucometer or continuous glucose monitor (CGM) immediately before the examination begins. The leading CGM brands are Dexcom and Abbott's FreeStyle Libre [22]Verified Dexcom G7 vs. FreeStyle Libre 3 and Libre 3 Plus: CGM Comparison
Confirms Dexcom and FreeStyle Libre as the two leading CGM brands; provides wear time and feature comparisons. If they use a CGM, the examiner should ask the examinee to show their current reading and trend arrow. A glucose value within range but trending sharply downward may still be problematic, as it suggests the examinee could become hypoglycemic during the examination.

The examiner should record the pre-test blood glucose reading, the time it was taken, the method used (glucometer or CGM), and the trend direction if available. If the reading is below 70 mg/dL or above 250 mg/dL, the examination should be postponed until the examinee's glucose is stabilized. Readings between 180-250 mg/dL warrant careful consideration; the examiner may proceed with documented notation of the elevated baseline but should be aware of potential impacts on channel clarity.

Scheduling and Preparation Recommendations

Timing of the examination should account for the examinee's diabetes management routine. Morning appointments (approximately 2-3 hours after breakfast and morning medications) are generally preferred for diabetic examinees, as this allows glucose levels to stabilize after the post-meal spike while avoiding the afternoon energy dip that can affect blood sugar.

Examinees should be instructed to eat a balanced meal 2-3 hours before the appointment, take their usual medications as prescribed, bring their diabetes management supplies (glucometer, test strips, CGM receiver, glucose tablets or fast-acting carbohydrate), and avoid skipping meals or dramatically altering their eating pattern on test day.

The examiner should also plan for the possibility of a glucose break during the examination. Unlike typical polygraph examinations where breaks are minimized, diabetic examinees may need to check their blood sugar, eat a snack, or treat a low blood sugar episode. These breaks should be accommodated without penalizing the examinee or assuming purposeful disruption. Proper in-test instructions and admonitions should include an explanation that the examinee can request a glucose break at any time.

Real-Time Monitoring and Examiner Protocols

During the examination itself, the examiner should be alert to signs of glucose fluctuation. Symptoms of hypoglycemia that may emerge during testing include sudden sweating (distinct from nervous perspiration in that it affects the face and neck), trembling hands, difficulty concentrating or answering questions, confusion, irritability, or pallor. If any of these signs appear, the examiner should pause the examination immediately and ask the examinee to check their blood sugar.

Symptoms of hyperglycemia may be less dramatic but equally problematic: excessive thirst, frequent need to urinate, headache, or fatigue. An examinee who requests multiple bathroom breaks may be experiencing osmotic diuresis from elevated blood glucose rather than attempting to disrupt the test.

The examiner should establish a protocol at the beginning of the examination: "If at any time you feel your blood sugar is getting too low or too high, please tell me immediately. We can pause the test for you to check your glucose and take appropriate action. This will not affect the outcome of your examination."

For examinees using CGMs, consider whether the CGM alarm should remain active during testing. While alarm sounds could introduce artifacts at unexpected moments, disabling alerts could allow dangerous glucose levels to go unnoticed. A reasonable compromise is to set the CGM to vibrate-only mode, allowing the examinee to be aware of alerts without audible disruption.

Documenting Diabetes in Polygraph Reports

Thorough documentation protects both the examiner and the examinee and enhances the defensibility of the examination results. The polygraph report should include the diagnosis (Type 1, Type 2, or gestational diabetes), the duration of diabetes, all diabetes-related medications with dosages and timing, the pre-test blood glucose reading and time, any glucose checks performed during the examination, any breaks taken for diabetes management, any observed symptoms of hypoglycemia or hyperglycemia, and the examiner's assessment of whether the examinee's diabetes may have affected the quality of the physiological data.

If the examiner notes channel-specific anomalies consistent with diabetic effects (e.g., flat electrodermal tracings suggesting sudomotor dysfunction, reduced heart rate variability suggesting CAN, or elevated baseline readings consistent with hyperglycemia), these should be explicitly noted. This is especially important for examiners who may be involved in psychopathy assessments or other complex evaluations where multiple factors may influence the physiological data.

Optimizing Test Conditions for Diabetic Examinees

The goal of all accommodations for diabetic examinees is to obtain the most valid, scorable charts possible while ensuring the examinee's medical safety. With proper preparation, the vast majority of people with well-managed diabetes can be tested successfully and produce valid results.

Examiners should schedule morning appointments when glucose tends to be most stable. Allow extra time — plan for up to 4 hours rather than the standard 2-3 hours to accommodate possible glucose breaks. Have glucose tablets or juice available in the testing room as an emergency measure. Maintain a comfortable room temperature, as extreme temperatures can affect both blood glucose levels and electrodermal activity.

During the pre-test phase, conduct a thorough medical screening that goes beyond a standard checklist. Ask specifically about diabetes duration, complications (especially neuropathy), medication regimen, and recent glucose control (HbA1c if known). This information helps the examiner set appropriate expectations for the quality of physiological data.

When scoring charts from diabetic examinees, apply the same numerical scoring criteria as for any other examinee, but document any channel-specific limitations. If one channel is compromised by neuropathy (e.g., flat EDA tracings), the examiner may need to rely more heavily on the remaining channels — a practice that should be explicitly documented and supported by the known limitations of single-channel diagnosis [11]Verified Relative Accuracy of Polygraph Examiner Diagnosis of Respiration, Blood Pressure, and GSR Recordings
Confirms electrodermal (GSR) measures provide the most diagnostic information of all polygraph channels. The use of multiple comparison question formats and careful attention to Menopause and hormonal effects can provide useful parallels for examiners dealing with physiological variability in diabetic subjects.